Concepedia

Zuliang Yao

ZY

Statistics

Publications

8

Citations

233

H-Index

8

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Zuliang Yao is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacy, and drug discovery.

Publications per year

1999–2017

8

Publications

8

Validation of Rat Endometriosis Model by Using Raloxifene as a Positive Control for the Evaluation of Novel SERM Compounds

Zuliang Yao, Xun Shen, Isabella Capodanno et al. · Journal of Investigative Surgery · 2005 · 61 citations

, , +7

Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 Diabetes

Wen‐Lian Wu, Jinsong Hao, Martin S. Domalski et al. · ACS Medicinal Chemistry Letters · 2016 · 45 citations · Full text

, , +14

Drug delivery of anticancer agents: water soluble 4-poly (ethylene glycol) derivatives of the lignan, podophyllotoxin

Richard B. Greenwald, Charles D. Conover, Annapurna Pendri et al. · Journal of Controlled Release · 1999 · 37 citations

, , +16

Quantifying rates of glucose production in vivo following an intraperitoneal tracer bolus

Shengping Wang, Dan Zhou, Zuliang Yao et al. · American Journal of Physiology-Endocrinology and Metabolism · 2016 · 21 citations · Full text

, , +12

Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR<sup>−</sup>rats

M.-S. Kim, D. Q. Liu, John R. Strauss et al. · Xenobiotica · 2003 · 19 citations

, , +14

1–5 of 8